KAYAK
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

KAYAK Trademark

Serial Number: 90272634

KAYAK is a trademark filed by Neurocrine Biosciences, Inc. on October 22, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Neurocrine Biosciences, Inc. (238 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

October 22, 2020

Registration Date

Not Registered

Published for Opposition

July 27, 2021

Goods & Services

Providing medical information; providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders

Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 28, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 28, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2024 EXRA
SOU EXTENSION 5 GRANTED
Mar 6, 2024 EX5G
SOU EXTENSION 5 FILED
Mar 6, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 6, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 21, 2023 EXRA
SOU EXTENSION 4 GRANTED
Sep 19, 2023 EX4G
SOU EXTENSION 4 FILED
Sep 19, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 19, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2023 EXRA
SOU EXTENSION 3 GRANTED
Feb 21, 2023 EX3G
SOU EXTENSION 3 FILED
Feb 21, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 21, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 1, 2022 EXRA
SOU EXTENSION 2 GRANTED
Aug 30, 2022 EX2G
SOU EXTENSION 2 FILED
Aug 30, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 30, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 23, 2022 EXRA
SOU EXTENSION 1 GRANTED
Mar 21, 2022 EX1G
SOU EXTENSION 1 FILED
Mar 21, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 21, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 21, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 27, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 21, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 21, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 21, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 21, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 17, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 17, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 17, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2020 NWOS
NEW APPLICATION ENTERED
Oct 26, 2020 NWAP